Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis
Top Cited Papers
Open Access
- 10 November 2015
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2015, 1-12
- https://doi.org/10.1155/2015/762820
Abstract
We systematically identified the prevalence of hyperuricemia and gout in mainland China and provided informative data that can be used to create appropriate local public health policies. Relevant articles from 2000 to 2014 were identified by searching 5 electronic databases: PubMed, Google Scholar, Chinese Wanfang, CNKI, and Chongqing VIP. All of the calculations were performed using the Stata 11.0 and SPSS 20.0 software. The eligible articles (; 3 in English and 33 in Chinese) included 44 studies (38 regarding hyperuricemia and 6 regarding gout). The pooled prevalence of hyperuricemia and gout was 13.3% (95% CI: 11.9%, 14.6%) and 1.1% (95% CI: 0.7%, 1.5%), respectively. Although publication bias was observed, the results did not change after a trim and fill test, indicating that that impact of this bias was likely insignificant. The prevalence of hyperuricemia and gout was high in mainland China. The subgroup analysis suggested that the geographical region, whether the residents dwell in urban or rural and coastal or inland areas, the economic level, and sex may be associated with prevalence. We systematically identified the prevalence of hyperuricemia and gout in mainland China and provided informative data that can be used to create appropriate local public health policies. Relevant articles from 2000 to 2014 were identified by searching 5 electronic databases: PubMed, Google Scholar, Chinese Wanfang, CNKI, and Chongqing VIP. All of the calculations were performed using the Stata 11.0 and SPSS 20.0 software. The eligible articles (; 3 in English and 33 in Chinese) included 44 studies (38 regarding hyperuricemia and 6 regarding gout). The pooled prevalence of hyperuricemia and gout was 13.3% (95% CI: 11.9%, 14.6%) and 1.1% (95% CI: 0.7%, 1.5%), respectively. Although publication bias was observed, the results did not change after a trim and fill test, indicating that that impact of this bias was likely insignificant. The prevalence of hyperuricemia and gout was high in mainland China. The subgroup analysis suggested that the geographical region, whether the residents dwell in urban or rural and coastal or inland areas, the economic level, and sex may be associated with prevalence.Keywords
This publication has 56 references indexed in Scilit:
- Systematic review of the prevalence of gout and hyperuricaemia in AustraliaInternal Medicine Journal, 2012
- Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based studyAnnals Of The Rheumatic Diseases, 2012
- The prevalence of hyperuricemia in China: a meta-analysisBMC Public Health, 2011
- Contemporary epidemiology of gout in the UK general populationArthritis Research & Therapy, 2011
- Large Epidemiologic Studies of Gout: Challenges in Diagnosis and Diagnostic CriteriaCurrent Rheumatology Reports, 2010
- Vitamin C Intake and the Risk of Gout in MenJAMA Internal Medicine, 2009
- Uric Acid and Cardiovascular RiskThe New England Journal of Medicine, 2008
- Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005Annals Of The Rheumatic Diseases, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Preliminary criteria for the classification of the acute arthritis of primary goutArthritis & Rheumatism, 1977